These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17456929)

  • 1. Use of fumaric acid esters in psoriasis.
    Roll A; Reich K; Boer A
    Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
    Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
    Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumaric acid esters.
    Rostami Yazdi M; Mrowietz U
    Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus.
    Mrowietz U; Barker J; Boehncke WH; Iversen L; Kirby B; Naldi L; Reich K; Tanew A; van de Kerkhof PCM; Warren RB
    J Eur Acad Dermatol Venereol; 2018 Oct; 32 Suppl 3():3-14. PubMed ID: 30238510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.
    Blair HA
    Drugs; 2018 Jan; 78(1):123-130. PubMed ID: 29236231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumaric acid esters for psoriasis: a systematic review.
    Smith D
    Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
    Kokelj F; Plozzer C; Avian A; Trevisan G
    Acta Dermatovenerol Croat; 2009; 17(3):170-5. PubMed ID: 19818215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylfumarate for psoriasis: more than a dietary curiosity.
    Mrowietz U; Asadullah K
    Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
    Litjens NH; van Strijen E; van Gulpen C; Mattie H; van Dissel JT; Thio HB; Nibbering PH
    BMC Pharmacol; 2004 Oct; 4():22. PubMed ID: 15479475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1999 Sep; 141(3):424-9. PubMed ID: 10584060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
    Dickel H; Bruckner T; Altmeyer P
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis.
    Warren RB; Barker JNW; Van de Kerkhof P; Reich K; Mrowietz U
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e352-e353. PubMed ID: 31033034
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients].
    Altmeyer P; Hartwig R; Matthes U
    Hautarzt; 1996 Mar; 47(3):190-6. PubMed ID: 8647701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumaric acid esters in the treatment of psoriasis: an Italian experience.
    Carboni I; De Felice C; De Simoni I; Soda R; Chimenti S
    J Dermatolog Treat; 2004 Jan; 15(1):23-6. PubMed ID: 14754645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
    Drugs R D; 2005; 6(4):229-30. PubMed ID: 15991882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study.
    Falkvoll S; Gerdes S; Mrowietz U
    J Dtsch Dermatol Ges; 2019 Sep; 17(9):906-912. PubMed ID: 30644638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl fumarate for treating relapsing multiple sclerosis.
    Sheremata W; Brown AD; Rammohan KW
    Expert Opin Drug Saf; 2015 Jan; 14(1):161-70. PubMed ID: 25382392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.